Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet

Amicus Therapeutics (FOLD) closed the last trading session at $9.87, gaining 11.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.64 indicates a 58.5% upside potential.The average comprises 11 short-term price targets ranging from a low of $11.00 to a high of $21.00, with a standard deviation of $3.29. While the lowest estimate indicates an increase of 11.5% from the current p ...